A detailed history of Chiron Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Chiron Investment Management, LLC holds 84,294 shares of BMY stock, worth $4.71 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares
84,294
Holding current value
$4.71 Million
% of portfolio
1.66%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$51.92 - $59.94 $4.38 Million - $5.05 Million
84,294 New
84,294 $4.77 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $627 - $370,676
4,824 New
4,824 $343,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Chiron Investment Management, LLC Portfolio

Follow Chiron Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Investment Management, LLC with notifications on news.